BPR Mrv0541 02241213272D 17 18 0 0 0 0 999 V2000 -0.7311 0.9235 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.9861 0.1389 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.5011 -0.5285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8367 -1.2822 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.8111 0.1389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.0660 0.9235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3986 1.4085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.3129 -2.4144 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.3193 -0.4423 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.7318 0.2722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8714 -1.0554 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 1.6250 -0.7198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.5388 0.1007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0848 -2.1173 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.6998 -1.8624 0.0000 B 0 0 0 0 0 0 0 0 0 0 0 0 -0.4093 0.2303 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 0.3073 -1.2065 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 1 7 1 0 0 0 0 2 3 1 6 0 0 0 2 5 1 0 0 0 0 2 16 1 1 0 0 0 3 4 2 0 0 0 0 3 9 1 0 0 0 0 5 6 1 0 0 0 0 6 7 1 0 0 0 0 8 15 1 0 0 0 0 9 10 1 0 0 0 0 9 11 1 0 0 0 0 10 13 1 0 0 0 0 11 12 1 0 0 0 0 11 15 1 1 0 0 0 11 17 1 6 0 0 0 12 13 1 0 0 0 0 14 15 1 0 0 0 0 M END > DB07482 > drugbank > [H][C@]1(CCCN1C(=O)[C@]1([H])CCCN1)B(O)O > InChI=1S/C9H17BN2O3/c13-9(7-3-1-5-11-7)12-6-2-4-8(12)10(14)15/h7-8,11,14-15H,1-6H2/t7-,8-/m0/s1 > XSBZZZGVAIXJLD-YUMQZZPRSA-N > C9H17BN2O3 > 212.054 > 212.133222886 > 4 > 32 > 0.9746848584961344 > 22.516438920759658 > 1 > 3 > 0 > 0 > [(2R)-1-[(2S)-pyrrolidine-2-carbonyl]pyrrolidin-2-yl]boronic acid > -0.52 > -1.2760133027468525 > -0.85 > 0 > 1 > 2 > 1 > 13.052574715051652 > 8.612153974797101 > 9.845528637023572 > 72.8 > 50.9088 > 2 > 1 > 3.02e+01 g/l > tetrahydrofolic acid > 0 > DB07482 > experimental > (2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE $$$$